Dr. Filippo Milano
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Acute Myelogenous Leukemia
Studies Myelodysplastic Syndrome
6 reported clinical trials
18 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
HLA-A positive
HLA-A negative
HLA negative
2Myelodysplastic Syndrome
HLA-A positive
HLA-A negative
HLA negative
Affiliated Hospitals
Clinical Trials Filippo Milano is currently running
Stem Cell Transplant
for Blood Cancers
This phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood cancers (hematological malignancies). Giving chemotherapy and total-body irradiation before a donor stem cell transplant helps stop the growth of cells in the bone marrow, including normal blood-forming cells (stem cells) and cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient, they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. The donated stem cells may also replace the patient's immune cells and help destroy any remaining cancer cells.
Recruiting1 award Phase 222 criteria
Chemotherapy + Stem Cell Transplant
for Leukemia and Related Disorders
This phase I trial studies the best dose of total body irradiation when given with cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) or idarubicin, fludarabine, cytarabine and filgrastim (FLAG-Ida) chemotherapy reduced-intensity conditioning regimen before stem cell transplant in treating patients with acute myeloid leukemia, myelodysplastic syndrome, or chronic myelomonocytic leukemia that has come back (relapsed) or does not respond to treatment (refractory). Giving chemotherapy and total body irradiation before a donor peripheral blood stem cell transplant helps kill cancer cells in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. When the healthy stem cells from a donor are infused into a patient, they may help the patient's bone marrow make more healthy cells and platelets and may help destroy any remaining cancer cells. Sometimes the transplanted cells from a donor can attack the body's normal cells called graft versus host disease. Giving cyclophosphamide, cyclosporine, and mycophenolate mofetil after the transplant may stop this from happening.
Recruiting1 award Phase 110 criteria
More about Filippo Milano
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Filippo Milano has experience with
- Total-Body Irradiation
- Cyclophosphamide
- Fludarabine
- Cyclosporine
- Mycophenolate Mofetil
- Thiotepa
Breakdown of trials Filippo Milano has run
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Biphenotypic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Filippo Milano specialize in?
Filippo Milano focuses on Acute Myelogenous Leukemia and Myelodysplastic Syndrome. In particular, much of their work with Acute Myelogenous Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Filippo Milano currently recruiting for clinical trials?
Yes, Filippo Milano is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Filippo Milano has studied deeply?
Yes, Filippo Milano has studied treatments such as Total-Body Irradiation, Cyclophosphamide, Fludarabine.
What is the best way to schedule an appointment with Filippo Milano?
Apply for one of the trials that Filippo Milano is conducting.
What is the office address of Filippo Milano?
The office of Filippo Milano is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.